Hony backed Consun Pharma launches $141m IPO

By Rev Hui
06 Dec 2013

Consun Pharmaceutical Group started marketing its HK$1.09bn ($141m) IPO on December 6 as it looks to join the slew of Chinese issuers listing on the Hong Kong Stock Exchange by the end of the year.

Like many of the other IPOs currently in the Hong Kong market, Consun is undergoing a shortened bookbuilding process that runs for less than a week with pricing expected to be announced on December 12.

Consun is offering investors 150m primary shares at an indicative price range of ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial